Sartorius AG, a leading global partner of the biopharmaceutical industry, is headquartered in Göttingen, Germany. Founded in 1870, the company has evolved significantly, establishing a strong presence in Europe, North America, and Asia. Sartorius operates primarily in the life sciences and laboratory equipment sectors, focusing on bioprocess solutions and laboratory instruments. The company is renowned for its innovative products, including high-precision balances, bioreactors, and filtration systems, which are designed to enhance productivity and ensure quality in biopharmaceutical manufacturing. Sartorius has achieved notable milestones, such as its commitment to sustainability and digital transformation, positioning itself as a market leader. With a strong emphasis on research and development, Sartorius continues to drive advancements in the industry, making it a trusted name among scientists and manufacturers worldwide.
How does Sartorius's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sartorius's score of 52 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of 2023, Sartorius reported total carbon emissions of approximately 896,898,000 kg CO2e, with Scope 1 emissions at about 13,103,000 kg CO2e, Scope 2 emissions at approximately 48,388,000 kg CO2e, and Scope 3 emissions reaching around 856,972,000 kg CO2e. The company has set ambitious climate commitments, aiming for net climate neutrality by 2045 across all scopes. Additionally, Sartorius has established a near-term target to reduce CO2 equivalent emission intensity by an average of 10% per year from 2019 levels by 2030. This commitment reflects the company's proactive approach to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Scope 1 | 7,738,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 16,018,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sartorius is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.